Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:07:41 UTC |
---|
Update Date | 2019-07-23 07:15:23 UTC |
---|
HMDB ID | HMDB0060927 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Hydroxylumiracoxib |
---|
Description | Hydroxylumiracoxib belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group. Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug, manufactured by Novartis and still sold in few countries, including Mexico, Ecuador and the Dominican Republic, under the trade name Prexige (sometimes misquoted as 'Prestige' by the media). Hydroxylumiracoxib is a metabolite of lumiracoxib. Hydroxylumiracoxib is an extremely weak basic (essentially neutral) compound (based on its pKa). Lumiracoxib has several distinctive features. |
---|
Structure | CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1 InChI=1S/C15H13ClFNO3/c1-8-2-3-13(9(4-8)5-14(20)21)18-15-11(16)6-10(19)7-12(15)17/h2-4,6-7,18-19H,5H2,1H3,(H,20,21) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C15H13ClFNO3 |
---|
Average Molecular Weight | 309.72 |
---|
Monoisotopic Molecular Weight | 309.056799199 |
---|
IUPAC Name | 2-{2-[(2-chloro-6-fluoro-4-hydroxyphenyl)amino]-5-methylphenyl}acetic acid |
---|
Traditional Name | {2-[(2-chloro-6-fluoro-4-hydroxyphenyl)amino]-5-methylphenyl}acetic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC1=CC(CC(O)=O)=C(NC2=C(Cl)C=C(O)C=C2F)C=C1 |
---|
InChI Identifier | InChI=1S/C15H13ClFNO3/c1-8-2-3-13(9(4-8)5-14(20)21)18-15-11(16)6-10(19)7-12(15)17/h2-4,6-7,18-19H,5H2,1H3,(H,20,21) |
---|
InChI Key | LUNFHOZKXHTOLG-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminotoluenes. These are organic aromatic compounds containing a benzene that carries a single methyl group and one amino group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Toluenes |
---|
Direct Parent | Aminotoluenes |
---|
Alternative Parents | |
---|
Substituents | - 3-fluorophenol
- P-aminophenol
- 3-chlorophenol
- Aminophenol
- 3-halophenol
- Aniline or substituted anilines
- Aminotoluene
- 1-hydroxy-2-unsubstituted benzenoid
- Halobenzene
- Fluorobenzene
- Phenol
- Chlorobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Amino acid or derivatives
- Amino acid
- Carboxylic acid derivative
- Carboxylic acid
- Secondary amine
- Monocarboxylic acid or derivatives
- Organonitrogen compound
- Organooxygen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Carbonyl group
- Hydrocarbon derivative
- Organic oxide
- Organopnictogen compound
- Organofluoride
- Organochloride
- Organohalogen compound
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Hydroxylumiracoxib,1TMS,isomer #1 | CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O[Si](C)(C)C)=C1 | 2427.7 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,1TMS,isomer #2 | CC1=CC=C(NC2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)C(CC(=O)O)=C1 | 2503.6 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,1TMS,isomer #3 | CC1=CC=C(N(C2=C(F)C=C(O)C=C2Cl)[Si](C)(C)C)C(CC(=O)O)=C1 | 2423.4 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TMS,isomer #1 | CC1=CC=C(NC2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)C(CC(=O)O[Si](C)(C)C)=C1 | 2492.0 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TMS,isomer #2 | CC1=CC=C(N(C2=C(F)C=C(O)C=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2400.2 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TMS,isomer #3 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)[Si](C)(C)C)C(CC(=O)O)=C1 | 2475.6 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,3TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2456.4 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,3TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2432.7 | Standard non polar | 33892256 | Hydroxylumiracoxib,3TMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C)C=C2Cl)[Si](C)(C)C)C(CC(=O)O[Si](C)(C)C)=C1 | 2672.3 | Standard polar | 33892256 | Hydroxylumiracoxib,1TBDMS,isomer #1 | CC1=CC=C(NC2=C(F)C=C(O)C=C2Cl)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2687.7 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,1TBDMS,isomer #2 | CC1=CC=C(NC2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)C(CC(=O)O)=C1 | 2746.8 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,1TBDMS,isomer #3 | CC1=CC=C(N(C2=C(F)C=C(O)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O)=C1 | 2663.6 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TBDMS,isomer #1 | CC1=CC=C(NC2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2963.4 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TBDMS,isomer #2 | CC1=CC=C(N(C2=C(F)C=C(O)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2882.7 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,2TBDMS,isomer #3 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O)=C1 | 2930.9 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,3TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 3139.3 | Semi standard non polar | 33892256 | Hydroxylumiracoxib,3TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2993.0 | Standard non polar | 33892256 | Hydroxylumiracoxib,3TBDMS,isomer #1 | CC1=CC=C(N(C2=C(F)C=C(O[Si](C)(C)C(C)(C)C)C=C2Cl)[Si](C)(C)C(C)(C)C)C(CC(=O)O[Si](C)(C)C(C)(C)C)=C1 | 2984.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylumiracoxib GC-MS (Non-derivatized) - 70eV, Positive | splash10-03dl-1291000000-c332e7828d3fe8ca0ff8 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylumiracoxib GC-MS (2 TMS) - 70eV, Positive | splash10-009i-6219400000-af02a7ac8130c23efff5 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Hydroxylumiracoxib GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 10V, Positive-QTOF | splash10-01ox-0092000000-327818fa05fa295e0cdb | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 20V, Positive-QTOF | splash10-03di-0290000000-1ff6b9cacf560390aa96 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 40V, Positive-QTOF | splash10-06r2-2590000000-1eb6cb521023b062cf9f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 10V, Negative-QTOF | splash10-0bt9-0079000000-05ffdb934d4afd3855a6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 20V, Negative-QTOF | splash10-08fu-0093000000-8eac879592f62025c511 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 40V, Negative-QTOF | splash10-0006-4390000000-aa0a4023913419f7bd9d | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 10V, Positive-QTOF | splash10-03dl-0093000000-a2ca65d2bfbbbd370622 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 20V, Positive-QTOF | splash10-03di-0091000000-bea4feb0d33c185c15ee | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 40V, Positive-QTOF | splash10-03dj-0390000000-1ebd4510f8ff84922d7c | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 10V, Negative-QTOF | splash10-08fr-0097000000-3142ae9ba40bf36138a7 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 20V, Negative-QTOF | splash10-06rx-3092000000-72b5fa093b672ca8f5e2 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Hydroxylumiracoxib 40V, Negative-QTOF | splash10-001i-9000000000-c2fa753da65a4bac80a1 | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|